Aims: MODY (maturity onset diabetes of the young) is a group of well-defined diseases clinically characterised by onset before age 25 years that does not require insulin treatment (at least initially) to prevent the formation of ketone bodies and autosomal dominant inheritance. Despite the importance of accurate classification, it is not always simple to catalogue the diagnosis of a young patient with diabetes, and genetic studies are often improperly used.
Methods: We describe the clinical features of patients negative for MODY2 and MODY3 and compared them to patients positive for these subtypes.
Results: All patients with MODY3 had been diagnosed before age 25 years and required drug therapy for blood glucose control. MODY2 patients were diagnosed at the first laboratory workup either incidentally or as part of gestational diabetes screening. The clinical description of the 19 patients negative for MODY2 and MODY3 showed that only two patients presented a clinical picture consistent with MODY3 and one patient with MODY2.
Conclusions: Clinical features can be used for early exclusion of a MODY2 or MODY3 diagnosis and may reduce the need for genetic testing.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.endonu.2011.05.002 | DOI Listing |
Exp Clin Endocrinol Diabetes
November 2024
Department of Internal Medicine, Gastroenterology and Diabetology, Franziskus Hospital Harderberg, Niels Stensen Hospitals, Georgsmarienhütte, Germany.
Endocrinol Diabetes Metab Case Rep
July 2024
Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan.
Summary: Maturity-onset diabetes of the young (MODY) is a group of monogenic forms of diabetes mellitus characterized by early-onset diabetes with dominant inheritance of beta-cell dysfunction. There are few reports of the coinheritance of glucokinase (GCK) and hepatocyte nuclear factor 1 alpha gene (HNF1A) variants underlying MODY in patients. Herein, we describe a case involving combinations of monoallelic GCK and HNF1A variants associated with MODY.
View Article and Find Full Text PDFClin Pediatr Endocrinol
April 2024
Department of Pediatrics and Child Health, Nihon University School of Medicine, Tokyo, Japan.
This study aimed to examine the clinical characteristics of young children diagnosed with maturity-onset diabetes (MODY) using urine glucose screening at schools. The study participants were 70 non-obese children who were clinically diagnosed with type 2 diabetes through urine glucose screening at schools in Tokyo between 1974 and 2020. Of these children, 55 underwent genetic testing, and 21 were finally diagnosed with MODY: MODY2 in eight, MODY3 in eight, MODY1 in four and MODY5 in one.
View Article and Find Full Text PDFZhonghua Yi Xue Yi Chuan Xue Za Zhi
July 2024
Department of Pediatrics, Ningbo Women and Children's Hospital, Ningbo, Zhejiang 315012, China.
Objective: To explore the clinical characteristics and molecular basis for children and adolescents with monogenic diabetes.
Methods: A retrospective analysis was carried out for the clinical manifestations and laboratory data of 116 children and adolescents diagnosed with diabetes at Ningbo Women and Children's Hospital from January 2020 to March 2023. Whole exome sequencing and mitochondrial gene sequencing were carried out on 21 children with suspected monogenic diabetes.
Medicina (Kaunas)
May 2024
Faculty of Medicine, Pontifical Catholic University of Ecuador, Quito 170143, Ecuador.
(1) : Maturity-onset diabetes of the young (MODY) is a group of diabetes caused by gene defects related to insulin secretion. MODY1, MODY2, and MODY3 are the most common and account for approximately 80% of all cases. Other types are relatively rare.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!